trastuzumab
Not Tagged
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)']
tils in her2+ bc 10% with til 50% (median 13%)
hr per 10% increase in tils: hr 0.0.86 (adj), similar effect with or w/o trastuzumab
no correlation of til w/age
til lower in er+, n-, lower grade tumors no group with very low risk of recurrence #asco23
Chief, Division of Breast Oncology @DanaFarber
Tennis fan
Mother of two teenage girls